Veterinary studies: green lipped mussel oil for dog osteoarthritis

For years, researchers have been exploring a remarkable marine ingredient: the New Zealand green-lipped mussel (Perna canaliculus), prized for its Omega-3 content and natural compounds that help support healthy joints.

A staple of traditional Māori cuisine, it is now backed by a growing body of clinical research in both people and dogs, with findings suggesting support for joint comfort, mobility and cartilage health.

Where the New Zealand green lipped mussel comes from

The green-lipped mussel is native to the clean waters of New Zealand, raised with care for the environment and local tradition. Mussels grow on long floating lines, feeding only on phytoplankton, without added feed or industrial inputs during farming, which supports purity and traceability. Since 2004, production has been managed through quotas to protect stocks and support sustainable aquaculture.

What makes it unique

Green-lipped mussel oil is especially notable for:

• An exceptionally high Omega-3 content (EPA, DHA and ETA) with well-documented anti-inflammatory benefits.
• Rare compounds such as furan fatty acids, known for powerful antioxidant activity and anti-inflammatory effects that can exceed those of EPA.
• Natural antioxidants such as xanthophyll carotenoids, which help shield cells from oxidative stress.

Green lipped mussel powder vs oil: what's the difference?

• Green-lipped mussel powder is made by drying and grinding the mussel. It retains proteins and glycosaminoglycans, but much of its Omega-3 content can be lost because these fatty acids are vulnerable to heat and oxidation.
• Green-lipped mussel oil is extracted with supercritical CO₂, delivering up to 15 times more Omega-3 and reaching peak blood levels six times faster than powder. Because the oil contains no protein, it may also be easier to tolerate for sensitive dogs.

In practice, green-lipped mussel oil is more concentrated and rapidly absorbed than powder, and is easy to administer in small daily amounts.

Why green lipped mussel oil is researched for joint health

Osteoarthritis is a chronic inflammatory condition that causes pain, stiffness and cartilage breakdown. Research suggests green-lipped mussel oil may help in several ways:

Natural support for inflammatory pathways

Research in Inflammopharmacology (1997) and Food Science and Biotechnology (2017) found that green-lipped mussel oil lowers several inflammatory mediators linked to joint pain, including:

• lower PGE2, TNF-α, IL-1β and IL-6 levels,
• inhibition of key inflammatory pathways, including COX, 5-LOX, NF-κB and MAPK,
• reduced activation of pro-inflammatory macrophages.

These mechanisms matter in veterinary care because they overlap with pathways targeted by anti-inflammatories commonly used to manage canine osteoarthritis.

Unique marine lipids with antioxidant benefits

Research published in PNAS (2011) identified specific compounds called furan fatty acids (F-acids) found naturally in the New Zealand green-lipped mussel. Scientists found that these lipids have strong antioxidant and anti-inflammatory activity, with greater efficacy than EPA in some experimental arthritis models.

These compounds may help curb oxidative stress and free radicals linked to chronic inflammation and gradual damage to joint tissue.

Potential protection for cartilage and joint tissue

A 2021 study in Bone Reports found that green-lipped mussel oil may help:

• slow the activity of cells that break down bone and cartilage,
• lower biomarkers tied to joint damage,
• and support a healthier inflammatory balance in joint tissue.

Together, these laboratory findings help explain why veterinary trials often report better mobility, joint comfort and movement in arthritic dogs given green-lipped mussel oil.

What veterinary studies say about green lipped mussel oil and dog joints

Research on green-lipped mussel oil has accelerated in recent years, reinforcing its key role in supporting mobility and joint comfort in dogs. Early results were encouraging; newer, more rigorous controlled trials now offer clearer evidence of benefits for osteoarthritis and other joint issues.

Green lipped mussel oil delivers a clear clinical improvement in pain and joint function in dogs, with no side effects observed.

Kang et al.

Visible clinical improvements in arthritic dogs — often within weeks

A 2024 study in the Journal of Veterinary Clinics tested green-lipped mussel oil in 15 dogs with osteoarthritis.

After 4 weeks of supplementation, researchers reported:

• a significant drop in pain scores,
• better mobility,
• and improved weight-bearing on the affected leg.

Outcomes were assessed with standard veterinary tools: the CBPI (Canine Brief Pain Inventory), the OAS (Orthopedic Assessment Score) and gait analysis using Peak Vertical Force (PVF).

Benefits were especially clear in dogs with mild to moderate osteoarthritis. No notable side effects were reported during the trial.

A 2012 study in the Thai Journal of Veterinary Medicine looked at green-lipped mussel oil in 84 dogs with osteoarthritis or degenerative spinal conditions.

After several weeks of supplementation, researchers found:

• clearer clinical signs in most dogs,
• less lameness and improved mobility,
• plus strong owner satisfaction with their dog's comfort.

For dogs with hip or shoulder osteoarthritis:

• over 90% showed clinical improvement in lameness,
• and nearly 87% of owners noticed a visible difference.

Notably, some dogs improved clinically even when X-rays showed little change, suggesting that benefits for pain and joint function can appear before imaging detects structural changes.

Better mobility in active working dogs

A 2024 study in the New Zealand Veterinary Journal tested green-lipped mussel oil in 32 working dogs with musculoskeletal issues. This double-blind, placebo-controlled trial tracked activity with collar-mounted accelerometers.

Researchers found:

• a significant rise in high-intensity activity among supplemented dogs,
• better locomotor performance,
• and an improved ability to keep up sustained effort.

The authors suggest that green-lipped mussel extract may be a promising nutritional option for supporting joint comfort and mobility in dogs with mild to moderate musculoskeletal pain.

Results comparable to NSAID anti-inflammatories

A 2019 study in BMC Veterinary Research tested green-lipped mussel oil in 79 dogs with hip or elbow osteoarthritis. Three groups were compared: green-lipped mussel oil alone, firocoxib (an NSAID) alone, and both combined.

After 4 weeks, researchers reported:

• significant gains in weight-bearing and movement across all three groups,
• lower pain scores on the CBPI (Canine Brief Pain Inventory),
• with the strongest outcomes in the green-lipped mussel oil plus firocoxib group.

The combined group also showed a significant drop in inflammatory markers (PGE2), pointing to an additional anti-inflammatory benefit from the green-lipped mussel.

Unlike the NSAID-only group, dogs receiving green-lipped mussel oil alone showed no rise in kidney markers, indicating good supplement tolerance.

A 2016 study in the Thai Journal of Veterinary Medicine compared green-lipped mussel oil with carprofen (an NSAID) in 40 dogs with hip or elbow osteoarthritis.

After 4 weeks of treatment, researchers found:

• a significant mobility boost in dogs given green-lipped mussel oil,
• lower orthopedic pain and lameness scores,
• and better weight-bearing on the affected leg on gait analysis (Peak Vertical Force, PVF).

The best outcomes came from combining green-lipped mussel oil + carprofen, suggesting that green-lipped mussel oil works well alongside conventional anti-inflammatories.

Outperforms fish oil in head-to-head trials

A 2015 study in the Thai Journal of Veterinary Medicine compared green-lipped mussel oil with fish oil in 66 dogs with hip and/or shoulder osteoarthritis.

In dogs supplemented with green-lipped mussel oil, researchers observed:

• a significant improvement in lameness and mobility within just two weeks,
• a better weight-bearing on the affected limb measured by Peak Vertical Force (PVF),
• along with improved joint range of motion (ROM).

The study also found lower levels of the joint biomarker WF6, which is linked to cartilage breakdown, suggesting that osteoarthritis progression may slow.

After 24 weeks, the green-lipped mussel oil group significantly outperformed fish oil alone, with no notable side effects reported during the study.

Green-lipped mussel, especially the highly absorbable green-lipped mussel oil in PERNIXOL®, is a well-documented natural option for supporting your dog's joint comfort.

Conclusion

New Zealand green-lipped mussel is more than a marine ingredient: it is a science-backed source of support for dogs with joint problems.

Rich in Omega-3s and antioxidants, it offers a unique combination:reduced inflammation,cartilage protection,improved mobility.

Extensive clinical research in humans and dogs supports these benefits, including less pain, a better gait and maintained mobility and everyday wellbeing. Well tolerated in the cited studies, green-lipped mussel can be used alongside standard veterinary care.

That is the science behind PERNIXOL®, our liquid joint supplement containing green-lipped mussel oil, a natural way to support your dog's daily mobility and comfort.

PERNIXOL®420

dogs over 20kg 420mg EPA+DHA per ml

PERNIXOL®210

dogs 10 to 20kg 210mg EPA+DHA per ml

PERNIXOL®70

dogs under 10kg 70mg EPA+DHA per ml

Scientific references

• S. McPhee, L.D. Hodges, P.F.A. Wright, P.M. Wynne, N. Kalafatis, D.W. Harney, T.A. Macrides,Anti-cyclooxygenase effects of lipid extracts from the New Zealand green-lipped mussel, Perna canaliculus, Comparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology, Volume 146, Issue 3, 2007, Pages 346-356, ISSN 1096-4959, https://doi.org/10.1016/j.cbpb.2006.11.001.
• A.P. Treschow, L.D. Hodges, P.F.A. Wright, P.M. Wynne, N. Kalafatis, T.A. Macrides,Novel anti-inflammatory ω-3 PUFAs from the New Zealand green-lipped mussel, Perna canaliculus, Comparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology, Volume 147, Issue 4,
  2007, Pages 645-656, ISSN 1096-4959, https://doi.org/10.1016/j.cbpb.2007.04.004.
• Chen J, Bao C, Cho SH, Lee HJ.Green lipped mussel oil complex suppresses lipopolysaccharide stimulated inflammation via regulating nuclear factor-κB and mitogen activated protein kinases signaling in RAW264.7 murine macrophages. Food Sci Biotechnol. 2017 Jun 8;26(3):815-822. doi: 10.1007/s10068-017-0091-5. PMID: 30263608; PMCID: PMC6049590.
• Siriarchavatana P, Kruger MC, Miller MR, Tian H, Wolber FM.Non-polar lipid from greenshell mussel (Perna canaliculus) inhibits osteoclast differentiation. Bone Rep. 2021 Sep 24;15:101132. doi: 10.1016/j.bonr.2021.101132. PMID: 34632003; PMCID: PMC8493498.
• Whitehouse, M.W. & Macrides, Theodore & Kalafatis, N & Betts, W.H. & Haynes, D.R. & Broadbent, J. (1997).Anti-inflammatory activity of a lipid fraction (lyprinol) from the NZ Green-Lipped Mussel. Inflammopharmacology. 5. 237-46. 10.1007/s10787-997-0002-0.
• Wakimoto T, Kondo H, Nii H, Kimura K, Egami Y, Oka Y, Yoshida M, Kida E, Ye Y, Akahoshi S, Asakawa T, Matsumura K, Ishida H, Nukaya H, Tsuji K, Kan T, Abe I.Furan fatty acid as an anti-inflammatory component from the green-lipped mussel Perna canaliculus. Proc Natl Acad Sci U S A. 2011 Oct 18;108(42):17533-7. doi: 10.1073/pnas.1110577108. Epub 2011 Oct 4. PMID: 21972415; PMCID: PMC3198329.
• Roberta Cardim Lessa, Belgheis Ebrahimi, Jenn Jury, Mary Sewell, Yiqi Xie, Yan Li, Jun Lu,Characterising bioactive components of green-lipped mussel via two extraction methods: in vitro assessment of antioxidant and immunomodulatory effects, International Journal of Food Science and Technology, Volume 59, Issue 7, July 2024, Pages 4546–4561, https://doi.org/10.1111/ijfs.17178
• Mongkhon, Natwadee & Nganvongpanit, Korakot & Kongtaweelert, Prachya. (2015). Effect of PCSO-524 on OABiomarkers and Weight-Bearing Properties in Canine Shoulder and Coxofemeral Osteoarthritis. Thai Journal of Veterinary Medicine. 45. 157-165. 10.56808/2985-1130.2632.
• Kwananocha, Irin & Vijarnsorn, Monchanok & Kashemsant, Narudee & Lekcharoensuk, Chalermpol. (2016).Effectiveness of disease modifying osteoarthritis agents and carprofen for treatment of canine osteoarthritis. The Thai veterinary medicine. 46. 363-371. 10.56808/2985-1130.2750.
• Mongkon, Natwadee. (2012).Preliminary Study of the Clinical Outcome of Using PCSO-524 Polyunsaturated Fatty Acid Compound in the Treatment of Canine Osteoarthritis and Degenerative Spinal Diseases. Thai Journal of Veterinary Medicine. 42. 311-318. 10.56808/2985-1130.2402.
• Vijarnsorn M, Kwananocha I, Kashemsant N, Jarudecha T, Lekcharoensuk C, Beale B, Peirone B, Lascelles BDX.The effectiveness of marine based fatty acid compound (PCSO-524) and firocoxib in the treatment of canine osteoarthritis. BMC Vet Res. 2019 Oct 17;15(1):349. doi: 10.1186/s12917-019-2110-7. Erratum in: BMC Vet Res. 2020 Dec 16;16(1):486. doi: 10.1186/s12917-020-02713-9. PMID: 31623621; PMCID: PMC6798752.
• N Cave, S Bolton & N Cogger (2024)A pilot study to detect the effects
  of a green-lipped mussel (Perna canaliculus) nutraceutical on working farm dogs with musculoskeletal abnormalities using accelerometry, New Zealand Veterinary Journal, 72:6, 323-333, DOI: 10.1080/00480169.2024.2379966
• Kang, Kyu-Won & Kim, Nam-Yul & Lim, Sung-Jun & Kang, Byung-Jae. (2024).Therapeutic Effect of Green-Lipped Mussel Oil on Pain and Functional Disability in Dogs with Clinical Osteoarthritis. Journal of Veterinary Clinics. 41. 350-358. 10.17555/jvc.2024.41.6.350.

Written by the R&D team at Laboratoire Sensilia, specialists in animal nutrition.